You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

idiopathic membranous nephropathy

Showing 1 - 25 of 3,419
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Membranous Nephropathy

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • Obinutuzumab Injection
  • (no location specified)
May 8, 2023

Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy Trial (Huaier granule, Renin-angiotensin-aldosterone system

Not yet recruiting
  • Nephropathy
  • +2 more
  • Huaier granule
  • +2 more
  • (no location specified)
Apr 20, 2023

Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)

Recruiting
  • Idiopathic Membranous Nephropathy
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Mar 23, 2023

Idiopathic Membranous Nephropathy Trial in Beijing

Recruiting
  • Idiopathic Membranous Nephropathy
    • Beijing, Beijing, China
    • +2 more
    Jan 18, 2023

    Prognostic Model of Rituximab in the Treatment of MN

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • (no location specified)
    Dec 28, 2022

    Prognostic Model of TAC in the Treatment of MN

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • (no location specified)
    Dec 28, 2022

    Prognostic Model of GC/CTX in the Treatment of MN

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • glucocorticoid + cytoxan
    • (no location specified)
    Dec 28, 2022

    Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • glucocorticoid + tacrolimus
    • (no location specified)
    Dec 28, 2022

    Nephrotic Syndrome, Proteinuria, Autoimmune Disease Trial run by the NIDDK (Rituximab Infusion, Oral Cyclosporine)

    Recruiting
    • Nephrotic Syndrome
    • +4 more
    • Rituximab Infusion
    • Oral Cyclosporine
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • (no location specified)
    Aug 22, 2022

    Glomerulonephritis, Membranous, Nephrotic Syndrome,Idiopathic Trial in Japan (Rituximab (genetical recombination), Placebo)

    Not yet recruiting
    • Glomerulonephritis, Membranous
    • Nephrotic Syndrome，Idiopathic
    • Rituximab (genetical recombination)
    • Placebo
    • Anjo, Aichi, Japan
    • +7 more
    Jun 13, 2023

    Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, Cyclophosphamide, Rituximab)

    Recruiting
    • Idiopathic Membranous Nephropathy
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 18, 2022

    High Incidence of Thrombotic Events in Patients With MN and DKD

    Active, not recruiting
    • Glomerulonephritis, Membranous
    • +3 more
    • Grouping based on previous laboratory results, no intervention.
    • Jinan, Shandong, China
      Qianfoshan Hospital
    Dec 7, 2022

    Hyperspectral Imaging Technique in CTX Treatment of IMN

    Not yet recruiting
    • Hyperspectral Imaging
    • +2 more
    • Microscopic hyperspectral imaging system
    • (no location specified)
    Apr 29, 2023

    Efficacy Trial in Beijing (Prednisone, ciclosporin and mycophenolate mofetil, Ponticelli Regimen)

    Completed
    • Efficacy
    • Prednisone, ciclosporin and mycophenolate mofetil
    • Ponticelli Regimen
    • Beijing, Beijing, China
    • +1 more
    Feb 2, 2022

    Hyperspectral Imaging Technique in the Treatment of IMN by TAC

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • +2 more
    • Tacrolimus for the treatment of IMN
    • (no location specified)
    Mar 31, 2023

    Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,

    Completed
    • Idiopathic Membranous Nephropathy
    • symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
    • experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
    • Paris, France
      Department of Nephrology , Tenon hospital - APHP
    Oct 18, 2021

    Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, MP and CTX)

    Terminated
    • Idiopathic Membranous Nephropathy
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Feb 2, 2022

    Idiopathic Membranous Nephropathy Trial in Aarhus (100 mg AP1189, Placebo)

    Recruiting
    • Idiopathic Membranous Nephropathy
    • 100 mg AP1189
    • Placebo
    • Aarhus, Denmark
      Aarhus Universitetshospital
    Sep 21, 2021

    T- and B-Cell Subpopulations in Membranous Nephropathy

    Recruiting
    • Membranous Nephropathy
    • +2 more
      • Istanbul, Turkey
        Istanbul University
      May 31, 2023

      Idiopathic Membranous Nephropathy Trial in Guangzhou (PLA2R, TSHD7A)

      Terminated
      • Idiopathic Membranous Nephropathy
      • PLA2R
      • TSHD7A
      • Guangzhou, Guangdong, China
        Nephrology Dept,Guangdong General Hospital
      Jun 16, 2020

      Chronic Stable Angina, Vascular Dementia, Idiopathic Membranous Nephropathy Trial in China (Danzhu Fuyuan Granule)

      Unknown status
      • Chronic Stable Angina
      • +2 more
      • Danzhu Fuyuan Granule
      • Beijing, Beijing, China
      • +6 more
      Jul 30, 2020

      Autoreactive B Cells in Membranous Nephropathy

      Recruiting
      • Membranous Nephropathy
      • In vitro assays.
      • Ranica, BG, Italy
        Centro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
      Nov 2, 2022

      Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)

      Not yet recruiting
      • Primary Membranous Nephropathy
      • (no location specified)
      May 16, 2023

      PLA2R-IgG4 Detection Kit

      Enrolling by invitation
      • Membranous Nephropathy - PLA2R Induced
      • Kidney Diseases-except Membranous Nephropathy
        • Hangzhou, China
          ZhejiangBiostar
        May 6, 2023